Insight - Oct. 6th, 2020
Insight
•
07-Oct-2020
Today on Insight, John and Josh Rosenstern discuss the COVID19 treatment of President Trump, and how it has come under fire. Brother Josh says the FDA has given an expedited approval of Remdesiver and dexamethasone which the President was given. The Rosenstern’s discuss the COVID19 concerns that put people in a high risk group with regards to age, weight and other high risk categories. Brother Josh addresses the addictions that have come about for people going through this current pandemic with regards to fear. He believes obesity has increased. No matter what the problem, the Rosenstern's remind that Jesus Christ can break the chains of all bondages. Brother Josh encourages all believers to be about the Lord’s business, praying and spreading the good news of the Gospel, and the wisdom will come from the Lord.
Up Next in Insight
-
Insight - September 26th, 2024
Today on Insight, John and Josh Rosenstern discuss the impact of the Biden Administration on small businesses in the United States. Statistics confirm bankruptcy filings among small business owners is up 61-percent. Inflation, high interests rates, and COVID loans have forced higher costs for d...
-
Insight - Oct. 4th, 2022
Today on Insight, John and Josh Rosenstern discuss the U.S. Supreme Court’s latest case evaluations regarding voting and the U.S. Constitution's stance on state legislatures and law making. Brother Josh explains the dynamic of districting and re-districting in a state and where these are to be v...
-
Insight Aug. 22nd, 2019
Today, John and Josh Rosenstern address the current immigration crisis on the American southern border and explain the problems in the American immigration system that have facilitated this situation.
